Dermatomyositis: Can Fish Oil Help? A Special Patient Webinar on the NIH FAST for DM Clinical Trial

MIHRA Foundation is pleased to host the NIH/NIEHS Environmental Autoimmunity Group who are conducting FAST for DM — the Fatty Acid Supplementation Trial for Dermatomyositis.

FAST for DM is an NIH clinical trial studying whether omega-3 fatty acid (fish oil) supplementation, together with a healthy study diet, can reduce dermatomyositis disease activity and improve strength, function, and quality of life.

During this webinar, the study team will explain:

• Why omega-3 fatty acids are being studied in dermatomyositis
• What the FAST for DM trial is designed to learn
• Who may be eligible to participate
• What participants can expect during the study
• How to learn more and connect with the NIH study team

The study is enrolling adults ages 18–60 with adult or juvenile dermatomyositis who meet eligibility criteria.

Register Here

Hosted by MIHRA Foundation

with the Environmental Autoimmunity Group, National Institute of Environmental Health Sciences (NIEHS), NIH Clinical Center